{"symbol":"PFE","fiscalQuarter":"Q4-2019","reportDate":"2020-01-28","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q4-2019","postBrief":{"headline":"Pfizer Misses on EPS \u2014 Stock Down 5.03%","keyNumbers":[{"metric":"EPS","actual":"$0.55","expected":"N/A","surprise":"-9.32%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management noted challenges in the competitive landscape.","They emphasized a focus on pipeline development moving forward."],"summary":"Overall, management expressed caution regarding market conditions. They highlighted ongoing investments in research and development."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a miss on EPS, which contributed to a 5.03% decline in stock price. The lack of revenue details and guidance may raise concerns among investors about the company's future performance. Management's cautious tone suggests they are aware of challenges ahead but remain focused on their product pipeline.","metaDescription":"Pfizer (PFE) Q4 2019 earnings: EPS missed expectations. Stock down 5.03%. Full breakdown."}}